CCTC — LataMed AI Cashflow Statement
0.000.00%
- $130.23m
- $130.63m
Annual cashflow statement for LataMed AI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | — | -3.26 | -0.207 |
| Non-Cash Items | 7.8 | 1.61 | 3.1 | 0 |
| Discontinued Operations | ||||
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -7.83 | -1.68 | 0.095 | 0.002 |
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.033 | -0.07 | -0.067 | -0.206 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | 0 | 0 | — |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.033 | 0.07 | 0.067 | 0.206 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 0 | 0 | 0 |